JP2011507836A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507836A5
JP2011507836A5 JP2010539381A JP2010539381A JP2011507836A5 JP 2011507836 A5 JP2011507836 A5 JP 2011507836A5 JP 2010539381 A JP2010539381 A JP 2010539381A JP 2010539381 A JP2010539381 A JP 2010539381A JP 2011507836 A5 JP2011507836 A5 JP 2011507836A5
Authority
JP
Japan
Prior art keywords
dioxolo
naphtho
cyclopenta
hydroxy
dodecahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539381A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507836A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2008/051489 external-priority patent/WO2009082342A1/en
Publication of JP2011507836A publication Critical patent/JP2011507836A/ja
Publication of JP2011507836A5 publication Critical patent/JP2011507836A5/ja
Pending legal-status Critical Current

Links

JP2010539381A 2007-12-20 2008-12-18 グルココルチコステロイド受容体アゴニストとして作用するステロイド誘導体 Pending JP2011507836A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1540407P 2007-12-20 2007-12-20
PCT/SE2008/051489 WO2009082342A1 (en) 2007-12-20 2008-12-18 Steroid derivatives acting as glucocorticosteroid receptor agonists

Publications (2)

Publication Number Publication Date
JP2011507836A JP2011507836A (ja) 2011-03-10
JP2011507836A5 true JP2011507836A5 (enExample) 2012-01-26

Family

ID=40801455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010539381A Pending JP2011507836A (ja) 2007-12-20 2008-12-18 グルココルチコステロイド受容体アゴニストとして作用するステロイド誘導体

Country Status (10)

Country Link
US (1) US20110160167A1 (enExample)
EP (1) EP2235037A1 (enExample)
JP (1) JP2011507836A (enExample)
KR (1) KR20100102121A (enExample)
CN (1) CN101945885A (enExample)
AU (1) AU2008341590A1 (enExample)
BR (1) BRPI0821139A2 (enExample)
CA (1) CA2707618A1 (enExample)
RU (1) RU2010124799A (enExample)
WO (1) WO2009082342A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207788A1 (en) 2007-10-04 2010-07-21 AstraZeneca AB Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
EP3407916B1 (en) 2016-01-29 2023-12-20 Merck Sharp & Dohme LLC Phosphonate linkers and their use to facilitate cellular retention of compounds
WO2018071736A1 (en) * 2016-10-14 2018-04-19 Van Andel Research Institute Structures and mechanism for the design of highly potent glucocorticoids
CN110105420A (zh) * 2019-06-04 2019-08-09 博诺康源(北京)药业科技有限公司 一种布地奈德杂质ep-zg的合成方法
WO2025231369A1 (en) * 2024-05-03 2025-11-06 Emory University Veragranine analogs, pharmaceutical compositions, and uses in managing pain or inflammatory conditions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3129218A (en) * 1961-11-01 1964-04-14 Merck & Co Inc 2-alkoxymethylene steroids of the androstane and pregnane series
US3072639A (en) * 1962-03-05 1963-01-08 Merck & Co Inc 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US3364203A (en) * 1965-09-09 1968-01-16 Syntex Corp 6, 7-methylene and 6, 7-halomethylene pyrazole pregnanes and processes for their preparation
US3471477A (en) * 1967-10-18 1969-10-07 Syntex Corp 6-gem-difluoro (3,2-c) and (2,3-d) pyrazole steroids
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
DE3540537A1 (de) * 1985-11-15 1987-05-21 Klaus Kurt Koelzer Verstaerkungsmaterial
WO2005063777A1 (en) * 2003-12-23 2005-07-14 Corus Pharma Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
EP2207788A1 (en) * 2007-10-04 2010-07-21 AstraZeneca AB Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides

Similar Documents

Publication Publication Date Title
RU2381224C2 (ru) Пиперидинаминобензимидазольные производные как ингибиторы репликации респираторного синцитиального вируса
DE60107221T2 (de) Indolin-2-on derivate und deren verwendung als liganden der ocytocin rezeptoren
EP2727918A1 (en) Compounds and Compositions as Protein Kinase Inhibitors
JP2011520832A5 (enExample)
JP2015516000A5 (enExample)
RU2014105624A (ru) Соединения индазола, способ их применения и фармацевтическая композиция
RU2015108933A (ru) 3-АМИНОЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ROBгаммаT И ИХ ПРИМЕНЕНИЯ
CZ296163B6 (cs) Karboxyamidy chinolinu jako inhibitory TNF a inhibitory PDE-IV
NZ515543A (en) Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
JP2005508967A5 (enExample)
JP2008525357A (ja) 抗ムスカリン活性を有するアゾール誘導体
JP2005529092A5 (enExample)
KR20020089372A (ko) 알파-2 길항제로서의 퀴놀린 유도체
EA012110B1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
KR20110117146A (ko) Cb2 수용체 효능활성이 있는 n-치환 포화 헤테로사이클릭 술폰 화합물
SU1625331A3 (ru) Способ получени N-/4-пиперидинил/бензамидов, их фармацевтически приемлемых солей присоединени кислоты, стереоизомерных форм или N-оксидов
RU2008147543A (ru) Агонисты мускариновых рецепторов, эффективные при лечении боли, болезни альцгеймера и шизофрении
JP2011524896A5 (enExample)
JP2018522929A5 (enExample)
RU2010124799A (ru) Производные стероидов, действующие в качестве агонистов глюкокортикостероидных рецепторов
JP2004507527A5 (enExample)
HUP0003219A2 (hu) Ftalazinszármazékok, eljárás előállításukra és e vegyületeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása erekciós diszfunkció kezelésére alkalmas gyógyászati készítmények előállítására
RU2332414C2 (ru) Производные аминобензимидазолов в качестве ингибиторов репликации респираторного синцитиального вируса
RU2009136246A (ru) Новые соединения 707 и их применение
JP2006519798A5 (enExample)